-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Therapeutic potential of hedgehog signaling inhibitors in cancer: rationale and clinical data
Blake T Aftab, Charles M Rudin
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of hedgehog signaling inhibitors in cancer: rationale and clinical data
Blake T Aftab, Charles M Rudin
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of hedgehog signaling inhibitors in cancer: rationale and clinical data
Blake T Aftab, Charles M Rudin
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of hedgehog signaling inhibitors in cancer: rationale and clinical data
Blake T Aftab, Charles M Rudin
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of hedgehog signaling inhibitors in cancer: rationale and clinical data
Blake T Aftab, Charles M Rudin
Therapeutic Perspective: Clinical Investigation
-
Therapeutic potential of hedgehog signaling inhibitors in cancer: rationale and clinical data
Blake T Aftab, Charles M Rudin
Therapeutic Perspective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Development of antibiotics for Gram-negatives: where now?
Matteo Bassetti, Francesca Ginocchio, Daniele Roberto, Giacobbe, Malgorzata Mikulska
Therapeutic Prospective: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation
-
Welcome to Clinical Investigation
E Michael Lewiecki
Review Article: Clinical Investigation